Niacin and NSAID for combination therapy

Details for Australian Patent Application No. 2009249600 (hide)

Owner Cerenis Therapeutics S.A.

Inventors Kravtzoff, Roger; Oniciu, Daniela Carmen; Wetterau, John R.; Scott, Robert A.; Dasseux, Jean-louis; Castan, Catherine; Keyserling, Constance H.; Autant, Pierre; Guillard, Herve; Zhu, Lingyu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009249600

PCT Pub. Number WO2009/142731

Priority 61/054,795 20.05.08 US; 61/102,335 02.10.08 US

Filing date 20 May 2009

Wipo publication date 26 November 2009

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/60 (2006.01) - Salicylic acid

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/142731 Priority application(s): WO2009/142731

6 September 2012 Alteration of Name

  The name of the applicant has been altered to Cerenis Therapeutics Holding S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009249602-Debris deflection devices

2009249589-Inhibitors of bacterial biofilm formation